Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population‐based study

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|41|9|856-866

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.9, 2015-05, pp. : 856-866

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: differentiating chronic idiopathic constipation from constipation‐predominant irritable bowel syndrome – possible and important? – Authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 12, 2015-06 ,pp. : 1300-1300

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: differentiating chronic idiopathic constipation from constipation‐predominant irritable bowel syndrome – possible and important?

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 12, 2015-06 ,pp. : 1299-1299

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 30, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Health-related quality of life, work productivity and health care resource use associated with constipation predominant irritable bowel syndrome

By DiBonaventura Marco   Sun Shawn X.   Bolge Susan C.   Wagner Jan-Samuel   Mody Reema  

Current Medical Research and Opinion, Vol. 27, Iss. 11, 2011-11 ,pp. : 2213-2222

Informa Healthcare

Access to resources Recommend Favorite

Tegaserod in the treatment of irritable bowel syndrome with constipation

By Saad Richard   Chey William D  

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 29-42

Future Medicine

Access to resources Recommend Favorite